Myeloid Leukemia — Trials

Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,530 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 862
Recruiting: 498
Ph III recruiting: 47
Growth YoY: +2.9%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (619)

clinicaltrialsPublishedShowing 301–350 of 621 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03622541	Using Sorafenib as a Salvage Treatment for Relapsed or Refractory Acute Myeloid Leukemia Carrying FLT3-ITD	completed	Phase 2	46	The University of Hong KongOTHER	1	Mar 30, 2020	clinicaltrials
NCT02252107	10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1	completed	Phase 2	46	Radboud University Medical CenterOTHER	2	Mar 19, 2020	clinicaltrials